SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marika Piciocchi, Romilda Cardin, Umberto Cillo, Alessandro Vitale, Andrea Cappon, Claudia Mescoli, Maria Guido, Massimo Rugge, Patrizia Burra, Annarosa Floreani, Fabio Farinati, Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus–related liver carcinogenesis, Translational Research, 2016, 168, 122

    CrossRef

  2. 2
    J.R. Kroep, A. Charehbili, R.E. Coleman, R.L. Aft, Y. Hasegawa, M.C. Winter, K. Weilbaecher, K. Akazawa, S. Hinsley, H. Putter, G.J. Liefers, J.W.R. Nortier, N. Kohno, Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials, European Journal of Cancer, 2016, 54, 57

    CrossRef

  3. 3
    Grégory Verdeil, Silvia A. Fuertes Marraco, Timothy Murray, Daniel E. Speiser, From T cell “exhaustion” to anti-cancer immunity, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2016, 1865, 1, 49

    CrossRef

  4. 4
    Manuel Weber, Christos Iliopoulos, Patrick Moebius, Maike Büttner-Herold, Kerstin Amann, Jutta Ries, Raimund Preidl, Friedrich W. Neukam, Falk Wehrhan, Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas, Oral Oncology, 2016, 52, 75

    CrossRef

  5. 5
    Yoshiyuki Kimura, Maho Sumiyoshi, Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells, European Journal of Pharmacology, 2015, 746, 115

    CrossRef

  6. 6
    Maho Sumiyoshi, Masahiko Taniguchi, Kimiye Baba, Yoshiyuki Kimura, Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots through the inhibited activation and differentiation of M2 macrophages, Phytomedicine, 2015, 22, 7-8, 759

    CrossRef

  7. 7
    Ming T. Cheah, James Y. Chen, Debashis Sahoo, Humberto Contreras-Trujillo, Anne K. Volkmer, Ferenc A. Scheeren, Jens-Peter Volkmer, Irving L. Weissman, CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer, Proceedings of the National Academy of Sciences, 2015, 112, 15, 4725

    CrossRef

  8. 8
    Austin Huy Nguyen, Ilya G Berim, Devendra K Agrawal, Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells, Expert Review of Clinical Immunology, 2015, 11, 7, 849

    CrossRef

  9. 9
    Carola H Ries, Sabine Hoves, Michael A Cannarile, Dominik Rüttinger, CSF-1/CSF-1R targeting agents in clinical development for cancer therapy, Current Opinion in Pharmacology, 2015, 23, 45

    CrossRef

  10. 10
    Yu-Qiong Yang, Jin-Hua Liang, Jia-Zhu Wu, Li Wang, Xiao-Yan Qu, Lei Cao, Xiao-Li Zhao, Dong-Ping Huang, Lei Fan, Jian-Yong Li, Wei Xu, Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma, Leukemia Research, 2015,

    CrossRef

  11. 11
    Emilia Licarete, Alina Sesarman, Manuela Banciu, Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems, Journal of Microencapsulation, 2015, 32, 7, 619

    CrossRef

  12. 12
    Naoki Urakawa, Soken Utsunomiya, Mari Nishio, Manabu Shigeoka, Nobuhisa Takase, Noriaki Arai, Yoshihiro Kakeji, Yu-ichiro Koma, Hiroshi Yokozaki, GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways, Laboratory Investigation, 2015, 95, 5, 491

    CrossRef

  13. 13
    Manoj K. Sabnani, Robin Rajan, Bradley Rowland, Vikram Mavinkurve, Laurence M. Wood, Alberto A. Gabizon, Ninh M. La-Beck, Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses, Nanomedicine: Nanotechnology, Biology and Medicine, 2015, 11, 2, 259

    CrossRef

  14. 14
    Chiara Castelli, Licia Rivoltini, Monica Rodolfo, Marcella Tazzari, Cristina Belgiovine, Paola Allavena, Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies, Cancer Immunology, Immunotherapy, 2015, 64, 1, 83

    CrossRef

  15. 15
    Ralph E. Vatner, Silvia C. Formenti, Myeloid-Derived Cells in Tumors: Effects of Radiation, Seminars in Radiation Oncology, 2015, 25, 1, 18

    CrossRef

  16. 16
    Fernando Torres Andón, María José Alonso, Nanomedicine and cancer immunotherapy – targeting immunosuppressive cells, Journal of Drug Targeting, 2015, 23, 7-8, 656

    CrossRef

  17. 17
    Yuan-Feng Tian, Kun Tang, Wei Guan, Tao Yang, Hua Xu, Qian-Yuan Zhuang, Zhang-Qun Ye, OK-432 Suppresses Proliferation and Metastasis by Tumor Associated Macrophages in Bladder Cancer, Asian Pacific Journal of Cancer Prevention, 2015, 16, 11, 4537

    CrossRef

  18. 18
    Hans Jørgen Aarstad, Olav K. Vintermyr, Elling Ulvestad, Helene H. Aarstad, Kenneth W. Kross, John. H. Heimdal, Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients, APMIS, 2015, 123, 4
  19. 19
    H. Matsumoto, S.-l. Koo, R. Dent, P. H. Tan, J. Iqbal, Role of inflammatory infiltrates in triple negative breast cancer, Journal of Clinical Pathology, 2015, 68, 7, 506

    CrossRef

  20. 20
    Kuan-Yin Shen, Li-Sheng Chang, Chih-Hsiang Leng, Shih-Jen Liu, Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact, Expert Review of Vaccines, 2015, 14, 3, 383

    CrossRef

  21. 21
    Gerhard Hamilton, Barbara Rath, Smoking, inflammation and small cell lung cancer: recent developments, Wiener Medizinische Wochenschrift, 2015, 165, 19-20, 379

    CrossRef

  22. 22
    Wenxiu Zhao, Yaping Xu, Jianfeng Xu, Duan Wu, Bixing Zhao, Zhenyu Yin, Xiaomin Wang, Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially, International Immunopharmacology, 2015, 26, 2, 314

    CrossRef

  23. 23
    Y Jiang, Y Li, B Zhu, T-cell exhaustion in the tumor microenvironment, Cell Death and Disease, 2015, 6, 6, e1792

    CrossRef

  24. 24
    Zohreh Amoozgar, Michael S. Goldberg, Targeting myeloid cells using nanoparticles to improve cancer immunotherapy, Advanced Drug Delivery Reviews, 2015, 91, 38

    CrossRef

  25. 25
    Alfred P. See, Jonathon J. Parker, Allen Waziri, The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression, Journal of Neuro-Oncology, 2015, 123, 3, 405

    CrossRef

  26. 26
    Marie-Agnès Doucey, Ioannis Xenarios, Toward a rational design of combination therapy in cancer, OncoImmunology, 2015, 4, 11, e1046674

    CrossRef

  27. 27
    W. Hu, X. Li, C. Zhang, Y. Yang, J. Jiang, C. Wu, Tumor-associated macrophages in cancers, Clinical and Translational Oncology, 2015,

    CrossRef

  28. 28
    Stefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, Vincenzo Bronte, Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages, Journal of Clinical Investigation, 2015, 125, 9, 3365

    CrossRef

  29. 29
    David S. Hong, Filip Janku, Aung Naing, Gerald S. Falchook, Sarina Piha-Paul, Jennifer J. Wheler, Siqing Fu, Apostolia M. Tsimberidou, Michael Stecher, Prasant Mohanty, John Simard, Razelle Kurzrock, Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer, Investigational New Drugs, 2015, 33, 3, 621

    CrossRef

  30. 30
    Eduardo Bonavita, Maria Rosaria Galdiero, Sebastien Jaillon, Alberto Mantovani, Immunotherapy of Cancer, 2015,

    CrossRef

  31. 31
    Christian Leporini, Marinella Patanè, Francesca Saullo, Pierandrea Rende, Luca Gallelli, Eugenio Donato Di Paola, Rosa Toscano, Maria Lucia, Marco Rossi, Giovambattista De Sarro, Emilio Russo, A Comprehensive Safety Evaluation of Trabectedin and Drug–Drug Interactions of Trabectedin-Based Combinations, BioDrugs, 2014, 28, 6, 499

    CrossRef

  32. 32
    Nam-Young Kang, Sung-Jin Park, Xiao Wei Emmiline Ang, Animesh Samanta, Wouter H. P. Driessen, Vasilis Ntziachristos, Kristine O. Vasquez, Jeffrey D. Peterson, Seong-Wook Yun, Young-Tae Chang, A macrophage uptaking near-infrared chemical probe CDnir7 for in vivo imaging of inflammation, Chemical Communications, 2014, 50, 50, 6589

    CrossRef

  33. 33
    A. Charehbili, S. van de Ven, V. T. H. B. M. Smit, E. Meershoek-Klein Kranenbarg, N. A. T. Hamdy, H. Putter, J. B. Heijns, L. J. C. van Warmerdam, L. Kessels, M. Dercksen, M. J. Pepels, E. Maartense, H. W. M. van Laarhoven, B. Vriens, M. N. Wasser, A. E. van Leeuwen-Stok, G. J. Liefers, C. J. H. van de Velde, J. W. R. Nortier, J. R. Kroep, Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01), Annals of Oncology, 2014, 25, 5, 998

    CrossRef

  34. 34
    Panagiotis Tsagozis, Martin Augsten, Pavel Pisa, All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages, International Immunopharmacology, 2014, 23, 1, 8

    CrossRef

  35. 35
    Caterina Peraldo-Neia, Giuliana Cavalloni, Marco Soster, Loretta Gammaitoni, Serena Marchiò, Francesco Sassi, Livio Trusolino, Andrea Bertotti, Enzo Medico, Lorenzo Capussotti, Massimo Aglietta, Francesco Leone, Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models, BMC Cancer, 2014, 14, 1, 918

    CrossRef

  36. 36
    Elodie Viry, Jerome Paggetti, Joanna Baginska, Takouhie Mgrditchian, Guy Berchem, Etienne Moussay, Bassam Janji, Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity, Biochemical Pharmacology, 2014, 92, 1, 31

    CrossRef

  37. 37
    Jacek Rolinski, Iwona Hus, Breaking immunotolerance of tumors: A new perspective for dendritic cell therapy, Journal of Immunotoxicology, 2014, 11, 4, 311

    CrossRef

  38. 38
    Akemi Kosaka, Takayuki Ohkuri, Hideho Okada, Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells, Cancer Immunology, Immunotherapy, 2014, 63, 8, 847

    CrossRef

  39. 39
    Kuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, Pele Chong, Shih-Jen Liu, Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide, Human Vaccines & Immunotherapeutics, 2014, 10, 11, 3241

    CrossRef

  40. 40
    Anthony Rongvaux, Tim Willinger, Jan Martinek, Till Strowig, Sofia V Gearty, Lino L Teichmann, Yasuyuki Saito, Florentina Marches, Stephanie Halene, A Karolina Palucka, Markus G Manz, Richard A Flavell, Development and function of human innate immune cells in a humanized mouse model, Nature Biotechnology, 2014, 32, 4, 364

    CrossRef

  41. 41
    Tina Verschuere, Jaan Toelen, Wim Maes, Françoise Poirier, Louis Boon, Thomas Tousseyn, Thomas Mathivet, Holger Gerhardt, Veronique Mathieu, Robert Kiss, Florence Lefranc, Stefaan W. Van Gool, Steven De Vleeschouwer, Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity, International Journal of Cancer, 2014, 134, 4
  42. 42
    Francesca Bellora, Roberta Castriconi, Alessandra Dondero, Paolo Carrega, Alberto Mantovani, Guido Ferlazzo, Alessandro Moretta, Cristina Bottino, Human NK cells and NK receptors, Immunology Letters, 2014, 161, 2, 168

    CrossRef

  43. 43
    Vinit Kumar, Dmitry I. Gabrilovich, Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment, Immunology, 2014, 143, 4
  44. 44
    Anders A. Tveita, Fredrik H. Schjesvold, Olav Sundnes, Ole Audun W. Haabeth, Guttorm Haraldsen, Bjarne Bogen, Indirect CD4+ T-cell-mediated elimination of MHC IINEG tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells, European Journal of Immunology, 2014, 44, 9
  45. 45
    J. Heiders, D. Wolf, Krebs und das Immunsystem, Forum, 2014, 29, 2, 105

    CrossRef

  46. 46
    David S Hong, David Hui, Eduardo Bruera, Filip Janku, Aung Naing, Gerald S Falchook, Sarina Piha-Paul, Jennifer J Wheler, Siqing Fu, Apostolia M Tsimberidou, Michael Stecher, Prasant Mohanty, John Simard, Razelle Kurzrock, MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study, The Lancet Oncology, 2014, 15, 6, 656

    CrossRef

  47. 47
    Alberto Mantovani, Macrophages, Neutrophils, and Cancer: A Double Edged Sword, New Journal of Science, 2014, 2014, 1

    CrossRef

  48. 48
    Simona Pisanti, Paola Picardi, Elena Ciaglia, Alba D’Alessandro, Maurizio Bifulco, Novel prospects of statins as therapeutic agents in cancer, Pharmacological Research, 2014, 88, 84

    CrossRef

  49. 49
    Alberto Mantovani, Annunciata Vecchi, Paola Allavena, Pharmacological modulation of monocytes and macrophages, Current Opinion in Pharmacology, 2014, 17, 38

    CrossRef

  50. 50
    Charles H. Lineweaver, Paul C. W. Davies, Mark D. Vincent, Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic model, BioEssays, 2014, 36, 9
  51. 51
    Zhi-Feng Miao, Ting-Ting Zhao, Feng Miao, Zhen-Ning Wang, Ying-Ying Xu, Xiao-Yun Mao, Jian Gao, Jian-Hua Wu, Xing-Yu Liu, Yi You, Hao Xu, Hui-Mian Xu, The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa shift peritoneal milky spot macrophages towards an M1 phenotype to dampen peritoneal dissemination, Tumor Biology, 2014, 35, 5, 4285

    CrossRef

  52. 52
    Philippe Icard, Perrine Kafara, Jean-Marc Steyaert, Laurent Schwartz, Hubert Lincet, The metabolic cooperation between cells in solid cancer tumors, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1846, 1, 216

    CrossRef

  53. 53
    Elena Voronov, Yaron Carmi, Ron N. Apte, The role IL-1 in tumor-mediated angiogenesis, Frontiers in Physiology, 2014, 5,

    CrossRef

  54. 54
    Anat Klein-Goldberg, Shelly Maman, Isaac P. Witz, The role played by the microenvironment in site-specific metastasis, Cancer Letters, 2014, 352, 1, 54

    CrossRef

  55. 55
    Francesca Bellora, Roberta Castriconi, Alessandra Dondero, Anna Pessino, Alessio Nencioni, Giovanni Liggieri, Lorenzo Moretta, Alberto Mantovani, Alessandro Moretta, Cristina Bottino, TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells, European Journal of Immunology, 2014, 44, 6
  56. 56
    Carlos Galmarini, Maurizio D'Incalci, Paola Allavena, Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment, Marine Drugs, 2014, 12, 2, 719

    CrossRef

  57. 57
    Thomas Brodowicz, Trabectedin in soft tissue sarcomas, Future Oncology, 2014, 10, 8s, s1

    CrossRef

  58. 58
    M D’Incalci, N Badri, C M Galmarini, P Allavena, Trabectedin, a drug acting on both cancer cells and the tumour microenvironment, British Journal of Cancer, 2014, 111, 4, 646

    CrossRef

  59. 59
    C. Garcia-Jimenez, J. M. Garcia-Martinez, A. Chocarro-Calvo, A. De la Vieja, A new link between diabetes and cancer: enhanced WNT/ -catenin signaling by high glucose, Journal of Molecular Endocrinology, 2013, 52, 1, R51

    CrossRef

  60. 60
    Bastian Höchst, Frank A. Schildberg, Pia Sauerborn, Yvonne A. Gäbel, Heidrun Gevensleben, Diane Goltz, Lukas C. Heukamp, Andreas Türler, Matthias Ballmaier, Friederike Gieseke, Ingo Müller, Jörg Kalff, Christian Kurts, Percy A. Knolle, Linda Diehl, Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion, Journal of Hepatology, 2013, 59, 3, 528

    CrossRef

  61. 61
    Isabelle Ray-Coquard, Biology of ovarian cancer and trabectedin mechanism of action, Future Oncology, 2013, 9, 12s, 11

    CrossRef

  62. 62
    Xiaoling Kong, Xianying Tang, Wenjiao Du, Jing Tong, Yutao Yan, Fang Zheng, Min Fang, Feili Gong, Zheng Tan, Extracellular acidosis modulates the endocytosis and maturation of macrophages, Cellular Immunology, 2013, 281, 1, 44

    CrossRef

  63. 63
    Weizhen Jia, Hiroyasu Kidoya, Daishi Yamakawa, Hisamichi Naito, Nobuyuki Takakura, Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors, The American Journal of Pathology, 2013, 182, 5, 1821

    CrossRef

  64. 64
    Soulafa Mamlouk, Ben Wielockx, Hypoxia-inducible factors as key regulators of tumor inflammation, International Journal of Cancer, 2013, 132, 12
  65. 65
    Ratana Lim, Martha Lappas, Clyde Riley, Niels Borregaard, Holger J Moller, Nuzhat Ahmed, Gregory E Rice, Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer, Journal of Ovarian Research, 2013, 6, 1, 5

    CrossRef

  66. 66
    Felix Klug, Hridayesh Prakash, Peter E. Huber, Tobias Seibel, Noemi Bender, Niels Halama, Christina Pfirschke, Ralf Holger Voss, Carmen Timke, Ludmila Umansky, Kay Klapproth, Knut Schäkel, Natalio Garbi, Dirk Jäger, Jürgen Weitz, Hubertus Schmitz-Winnenthal, Günter J. Hämmerling, Philipp Beckhove, Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy, Cancer Cell, 2013, 24, 5, 589

    CrossRef

  67. 67
    Chao-Ying Liu, Juan-Ying Xu, Xiao-Yan Shi, Wei Huang, Ting-Yan Ruan, Ping Xie, Jun-Li Ding, M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway, Laboratory Investigation, 2013, 93, 7, 844

    CrossRef

  68. 68
    Sylvia Hartmann, Thomas Tousseyn, Claudia Döring, Patricia Flüchter, Holger Hackstein, An Herreman, Maurilio Ponzoni, Chris Wolf-Peeters, Fabio Facchetti, Randy D. Gascoyne, Ralf Küppers, Christian Steidl, Martin-Leo Hansmann, Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype, International Journal of Cancer, 2013, 133, 11
  69. 69
    Céline Robert-Tissot, Linh T Nguyen, Pamela S Ohashi, Daniel E Speiser, Mobilizing and evaluating anticancer T cells: pitfalls and solutions, Expert Review of Vaccines, 2013, 12, 11, 1325

    CrossRef

  70. 70
    David M. Richards, Jan Hettinger, Markus Feuerer, Monocytes and Macrophages in Cancer: Development and Functions, Cancer Microenvironment, 2013, 6, 2, 179

    CrossRef

  71. 71
    Aniruddha Roy, Manu Smriti Singh, Pramod Upadhyay, Sangeeta Bhaskar, Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model, International Journal of Pharmaceutics, 2013, 445, 1-2, 171

    CrossRef

  72. 72
    Kathrin Aprile von Hohenstaufen, Annarita Conconi, Cassio Polpo Campos, Silvia Franceschetti, Francesco Bertoni, Gloria Margiotta Casaluci, Anastasios Stathis, Michele Ghielmini, Georg Stussi, Franco Cavalli, Gianluca Gaidano, Emanuele Zucca, Prognostic impact of monocyte count at presentation in mantle cell lymphoma, British Journal of Haematology, 2013, 162, 4
  73. 73
    John D. Merriman, Diane Von Ah, Christine Miaskowski, Bradley E. Aouizerat, Proposed Mechanisms for Cancer- and Treatment-Related Cognitive Changes, Seminars in Oncology Nursing, 2013, 29, 4, 260

    CrossRef

  74. 74
    Martin Thurnher, Georg Gruenbacher, Oliver Nussbaumer, Regulation of mevalonate metabolism in cancer and immune cells, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013, 1831, 6, 1009

    CrossRef

  75. 75
    Giovanni Germano, Roberta Frapolli, Cristina Belgiovine, Achille Anselmo, Samantha Pesce, Manuela Liguori, Eugenio Erba, Sarah Uboldi, Massimo Zucchetti, Fabio Pasqualini, Manuela Nebuloni, Nico van Rooijen, Roberta Mortarini, Luca Beltrame, Sergio Marchini, Ilaria Fuso Nerini, Roberta Sanfilippo, Paolo G. Casali, Silvana Pilotti, Carlos M. Galmarini, Andrea Anichini, Alberto Mantovani, Maurizio D’Incalci, Paola Allavena, Role of Macrophage Targeting in the Antitumor Activity of Trabectedin, Cancer Cell, 2013, 23, 2, 249

    CrossRef

  76. 76
    Anthony Covarrubias, Vanessa Byles, Tiffany Horng, ROS sets the stage for macrophage differentiation, Cell Research, 2013, 23, 8, 984

    CrossRef

  77. 77
    Ranjana Mazumdar, Paul Evans, Rachel Culpin, James Bailey, David Allsup, The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapy, Leukemia Research, 2013, 37, 6, 614

    CrossRef

  78. 78
    Fengjiao Yuan, Ping Dong, Xiang Wang, Xiao Fu, Mingjun Dai, Weiyun Zhang, Toxicological effects of cigarette smoke on Ana-1 macrophages in vitro, Experimental and Toxicologic Pathology, 2013, 65, 7-8, 1011

    CrossRef

  79. 79
    Maurizio D’Incalci, Trabectedin mechanism of action: what’s new?, Future Oncology, 2013, 9, 12s, 5

    CrossRef

  80. 80
    Maria Rosaria Galdiero, Eduardo Bonavita, Isabella Barajon, Cecilia Garlanda, Alberto Mantovani, Sébastien Jaillon, Tumor associated macrophages and neutrophils in cancer, Immunobiology, 2013, 218, 11, 1402

    CrossRef

  81. 81
    Andreas Carus, Morten Ladekarl, Henrik Hager, Hans Pilegaard, Patricia S. Nielsen, Frede Donskov, Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome, Lung Cancer, 2013, 81, 1, 130

    CrossRef

  82. 82
    Bharat K Majeti, Joseph H Lee, Brett H Simmons, Farbod Shojaei, VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma, BMC Cancer, 2013, 13, 1, 213

    CrossRef

  83. 83
    Marij J.P. Welters, Sjoerd H. van der Burg, Cancer Immunotherapy, 2013,

    CrossRef

  84. 84
    Mariacristina Chioda, Ilaria Marigo, Susanna Mandruzzato, Simone Mocellin, Vincenzo Bronte, Cancer Immunotherapy, 2013,

    CrossRef

  85. 85
    Yoshio Sakai, Isamu Tatsumi, Mami Higashimoto, Akihiro Seki, Alessandro Nasti, Keiko Yoshida, Kazunori Kawaguchi, Takashi Wada, Masao Honda, Takuya Komura, Shuichi Kaneko, Association of changes in the gene expression profile of blood cells with the local tumor inflammatory response in a murine tumor model, Biochemical and Biophysical Research Communications, 2012, 428, 1, 36

    CrossRef

  86. 86
    M. Peakman, Broadening the translational immunology landscape, Clinical & Experimental Immunology, 2012, 170, 3
  87. 87
    Barbara Sennino, Donald M. McDonald, Controlling escape from angiogenesis inhibitors, Nature Reviews Cancer, 2012, 12, 10, 699

    CrossRef

  88. 88
    Lukas Baitsch, Silvia A. Fuertes-Marraco, Amandine Legat, Christiane Meyer, Daniel E. Speiser, The three main stumbling blocks for anticancer T cells, Trends in Immunology, 2012, 33, 7, 364

    CrossRef

  89. 89
    K. L. Tan, D. W. Scott, F. Hong, B. S. Kahl, R. I. Fisher, N. L. Bartlett, R. H. Advani, R. Buckstein, L. M. Rimsza, J. M. Connors, C. Steidl, L. I. Gordon, S. J. Horning, R. D. Gascoyne, Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial, Blood, 2012, 120, 16, 3280

    CrossRef